Brain scan study aims to spot Alzheimer's years early

NCT ID NCT05138263

Ongoing Knowledge-focused Sponsor: Seoul National University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 640 adults with normal cognition, mild cognitive impairment, or Alzheimer's disease to track brain changes over time. Researchers use advanced brain scans and genetic tests to understand how Alzheimer's develops. The goal is to find better ways to diagnose and predict the disease early.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors detect Alzheimer's earlier and predict who might develop it, leading to better planning and care.
What could go wrong: This is an observational study, not a treatment trial. It may not directly lead to new therapies, and results may take years to apply in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE MILD COGNITIVE IMPAIRMENT

Contacts and locations

Locations

SMG-SNU Boramae Medical Center

Seoul, Seoul, South Korea
Seoul National University Hospital

Seoul, 03080, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.